beta-Propiolactone

Novomer to Probe Functional Beta-Lactones to Enhance Virus Deactivation

Retrieved on: 
Wednesday, June 17, 2020

New functional beta-lactone architectures may have improved performance relative to beta-propiolactone owing to differences in lipophilicity and reactivity with functional groups commonly found in viruses.

Key Points: 
  • New functional beta-lactone architectures may have improved performance relative to beta-propiolactone owing to differences in lipophilicity and reactivity with functional groups commonly found in viruses.
  • Novel functionalized beta-propiolactones may unlock the key to selectively targeting the virus RNA for successful inactivation.
  • By utilizing Novomers catalyst and process technology, these novel materials can be produced in high volumes and high quality required for this important application, says Geoff Coates, Novomer Co-Founder.
  • Novomer, Inc. is a leading developer of chemical conversion technology to address market needs for transformable, functional, and high carbon utility materials.